Mingqing Zhu

1.3k citations

53 papers · 809 indexed · 1 hit paper · h-index 11

Co-authors: Depei Wu Xiaowen Tang Xiaming Zhu Haiping Dai Changgeng Ruan Guanghua Chen Jia Yin Jianhua Yu
Topics: Acute Myeloid Leukemia Research (23 papers)Acute Lymphoblastic Leukemia research (10 papers)Hematopoietic Stem Cell Transplantation (8 papers)
Cited by: Hematology Immunology Oncology
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaBlood
Partner nations: China United States Pakistan

In The Last Decade

Mingqing Zhu

50 papers receiving 803 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.

2018 356 citations Xiaowen Tang, Haiping Dai et al. PubMed profile →

Peers

Countries citing papers authored by Mingqing Zhu

Since Specialization

Citations

This map shows the geographic impact of Mingqing Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqing Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqing Zhu more than expected).

Fields of papers citing papers by Mingqing Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingqing Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqing Zhu. The network helps show where Mingqing Zhu may publish in the future.

Co-authorship network of co-authors of Mingqing Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingqing Zhu. A scholar is included among the top collaborators of Mingqing Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqing Zhu. Mingqing Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct clinical profiles and patient outcomes in aCML and CNL 2024 ·Annals of Hematology ·Yingxin Sun,Qinrong Wang,Zhiyu Zhang,Qian Wang,Jiannong Cen,Mingqing Zhu,Jinlan Pan,Dandan Liu,Hongjie Shen,Yifeng Cai,Suning Chen	3
2	Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial 2024 ·Signal Transduction and Targeted Therapy ·(unknown),Jia Chen,Tianhui Liu,Yishan Ye,Yanming Zhang,(unknown),Hong Liu,Mingqing Zhu,Xiao Ma,Xiaoli Li,Longfei Zhao,Zhihong Lin,He Huang,Yang Xu,Depei Wu	3
3	Distributed fusion filtering for multi-rate nonlinear systems with binary measurements under encryption and decryption scheme 2024 ·Information Fusion ·Jun Hu,(unknown),R. Caballero‐Águila,Mingqing Zhu,Guangchen Zhang	1
4	Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial 2023 ·Blood ·(unknown),Jia Chen,Tianhui Liu,Yanming Zhang,Yishan Ye,(unknown),Mingqing Zhu,Xiao Ma,Xiaoli Li,Zhihong Lin,He Huang,Yang Xu,Depei Wu	1
5	Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia 2023 ·Annals of Hematology ·Yingxin Sun,Qinrong Wang,Xingxia Zhang,Zhiyu Zhang,Qian Wang,Jiannong Cen,Mingqing Zhu,Jinlan Pan,Dandan Liu,Depei Wu,Yifeng Cai,Suning Chen	8
6	The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation 2021 ·Frontiers in Oncology ·Chang Hou,Lili Zhou,(unknown),(unknown),Hongjie Shen,Mingqing Zhu,Jia Chen,Miao Miao,Yang Xu,Depei Wu	4
7	A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS 2021 ·Frontiers in Oncology ·Qian Wang,Ling Zhang,Mingqing Zhu,Zhao Zeng,(unknown),(unknown),Jinlan Pan,Chunxiao Wu,Ni Wu,Ri Zhang,Suning Chen,Haiping Dai	1
8	Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World 2021 ·Frontiers in Oncology ·Yingxin Sun,Yifeng Cai,Jiannong Cen,Mingqing Zhu,Jinlan Pan,Qian Wang,Depei Wu,Suning Chen	4
9	Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia 2021 ·Frontiers in Oncology ·Xinyue Zhang,Haiping Dai,Zheng Li,Jia Yin,(unknown),Chunxiao Yang,Sheng Xiao,Mingqing Zhu,Dandan Liu,Hong Liu,Hongjie Shen,Depei Wu,Xiaowen Tang	7
10	HLA-mismatched stem cell microtransplantation compared to matched-sibling donor transplantation for intermediate/high-risk acute myeloid leukemia 2019 ·Annals of Hematology ·Limin Liu,Xingxia Zhang,Huiying Qiu,Xiaowen Tang,Yue Han,Chengcheng Fu,Zhengming Jin,Mingqing Zhu,Miao Miao,Depei Wu	9
11	Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma 2018 ·Cellular Physiology and Biochemistry ·(unknown),Bin Liu,Shoubao Ma,Jubin Zhang,(unknown),(unknown),Mingqing Zhu,Suning Chen,Xiaojin Wu,Depei Wu	19
12	Efficacy of immunomodulatory therapy with all- trans retinoid acid in adult patients with chronic immune thrombocytopenia 2016 ·Thrombosis Research ·Lan Dai,Ri Zhang,Zhaoyue Wang,Yang He,Xia Bai,Mingqing Zhu,Ziqiang Yu,Changgeng Ruan	19
13	[Clinical and laboratory characteristics of 12 Ph/BCR-ABL positive acute myeloid leukemia patients]. 2015 ·PubMed ·(unknown),(unknown),Suning Chen,Aining Sun,Jun He,Mingqing Zhu,Depei Wu	2
14	An improved flow cytometric immunobead array to detect autoantibodies in plasma from patients with immune thrombocytopenic purpura 2014 ·Clinica Chimica Acta ·Yunxiao Zhao,Mingqing Zhu,Miao Jiang,Bin Zuo,Qingyu Wu,Changgeng Ruan,Yang He	7
15	Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient 2012 ·International Journal of Hematology ·Dandan Liu,Suning Chen,Jinlan Pan,Mingqing Zhu,(unknown),Feng Zhu,Zixing Chen	4
16	Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting 2011 ·Journal of Biological Chemistry ·Xiaofei Qi,Jingjing Jiang,Mingqing Zhu,Qingyu Wu	35
17	Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma 2009 ·International Journal of Hematology ·Hongyu Bao,Miao Jiang,Mingqing Zhu,Fei Sheng,Jia Ruan,Changgeng Ruan	79
18	[Immunophenotypic and cytogenetic features in 51 cases of chronic lymphocytic leukemia]. 2007 ·PubMed ·(unknown),(unknown),Mingqing Zhu,Dandan Liu,Zixin Chen,Yongquan Xue	2
19	Expression and characterization of the ScFv fragment of antiplatelet GPIIIa monoclonal antibody SZ-21 2002 ·Thrombosis Research ·Guangyu An,Ningzheng Dong,Bojing Shao,Mingqing Zhu,Changgeng Ruan	8
20	[Preparation and characterization of a single chain antibody fragment of mAb SZ-21 against platelets GPIIIa]. 2002 ·PubMed ·Guangyu An,Ningzheng Dong,Bojing Shao,Mingqing Zhu,Changgeng Ruan	4

About Mingqing Zhu

Mingqing Zhu is a scholar working on Hematology, Cancer Research and Immunology, having authored 53 papers that have together received 809 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Acute Lymphoblastic Leukemia research (10 papers) and Hematopoietic Stem Cell Transplantation (8 papers). The work is most often cited by research in Hematology (278 citations), Immunology (380 citations) and Oncology (439 citations). Mingqing Zhu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Depei Wu, Xiaowen Tang, Xiaming Zhu, Haiping Dai, Changgeng Ruan, Guanghua Chen, Jia Yin, Jianhua Yu, Wenhong Shen and Lin Yang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact